Optimal time of tumour response evaluation and effectiveness of hypofractionated proton beam therapy for inoperable or recurrent hepatocellular carcinoma
Tae Hyun Kim(Sookmyung Women's University), Chang‐Min Kim(National Cancer Center), Young-Hwan Koh(National Cancer Center), Ju‐Hee Lee(Dongguk University), Woo Jin Lee, Sang Soo Kim(National Cancer Center), Bo Hyun Kim(Harvard University), Sung Ho Moon(Institute of Bioorganic Chemistry), Joong‐Won Park(National Cancer Center), Dae Yong Kim(National Cancer Center), Sang Myung Woo
Cited by 22
Related Papers
Global patterns of hepatocellular carcinoma management from diagnosis to death: the <scp>BRIDGE</scp> Study
|Liver International|2015|1.3k
Brivanib Versus Sorafenib As First-Line Therapy in Patients With Unresectable, Advanced Hepatocellular Carcinoma: Results From the Randomized Phase III BRISK-FL Study
|Journal of Clinical Oncology|2013|775
Predicting Radiation Pneumonitis After Chemoradiation Therapy for Lung Cancer: An International Individual Patient Data Meta-analysis
|International Journal of Radiation Oncology*Biology*Physics|2013|673